Skip to main content
Powered by ShareScore

Find research datasets worth reusing

Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.

477

datasets available to search

ShareScore release 0.9.0

Reset

Dataset results

477 results for “pancreatic ductal adenocarcinoma”

Learn how ShareScore rates datasets ↗
zenodo32/100

Peng2019 PRJCA001063 Pancreatic Ductal Adenocarcinoma Dataset for Besca

<p>The gene expression matrix was downloaded from BIGD-BioProject (https://bigd.big.ac.cn/bioproject/browse/PRJCA001063), originally published by Peng J, Sun BF, Chen CY, et al. Single-cell RNA-seq highlights intra-tumoral heterogeneity and malignant progression in pancreatic ductal adenocarcinoma [published correction appears in Cell Res. 2019 Aug 13;:]. Cell Res. 2019;29(9):725-738. doi:10.1038/s41422-019-0195-y. We reprocessed the dataset using the Besca package (https://github.com/bedapub/besca).</p>

opencc-by-4.0Jul 2020View details →
zenodo32/100

Mass cytometry data for "High-dimensional mass cytometry reveals stemness state heterogeneity in pancreatic ductal adenocarcinoma"

<p>Raw suspension mass cytometry data supporting the publication "High-dimensional mass cytometry reveals stemness state heterogeneity in pancreatic ductal adenocarcinoma".</p>

opencc-by-4.0Mar 2024View details →
zenodo32/100

Pancreatic Ductal Adenocarcinoma Spatial Transcriptomics

Open the record for dataset details and reuse information.

opencc-by-4.0Aug 2024View details →
zenodo32/100

Cell cycle heterogeneity in pancreatic ductal adenocarcinoma

<p>Multiplexed, single-cell imaging data for PDAC cell lines.</p>

opencc-by-4.0Apr 2023View details →
ClinicalTrials.gov32/100

The Effects of Neoadjuvant Metformin on Tumour Cell Proliferation and Tumour Progression in Pancreatic Ductal Adenocarcinoma

ClinicalTrials.gov study NCT02978547. IPD Sharing: Not stated. Countries: 1. Publications: 49.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

Perioperative Cancer Cell Dissemination and Systemic Immune Suppression in Resectable Ductal Pancreatic Adenocarcinoma

ClinicalTrials.gov study NCT00495924. IPD Sharing: Not stated. Countries: 1. Publications: 2.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

The Prognostic Impact of Surufatinib for the Treatment of Advanced Pancreatic Ductal Adenocarcinoma

ClinicalTrials.gov study NCT06378580. IPD Sharing: NO. Countries: 1. Publications: 1.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov32/100

ProAgio in Pancreatic Ductal Adenocarcinoma (PDAC)

ClinicalTrials.gov study NCT06182072. IPD Sharing: Not stated. Countries: 1. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

A Pilot Study of Ciprofloxacin Plus Gemcitabine and Nab-Paclitaxel Chemotherapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma.

ClinicalTrials.gov study NCT04523987. IPD Sharing: Not stated. Countries: 1. Publications: 2.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

Oncological Safety of Spleen Preservation in Left Pancreatectomy for Pancreatic Ductal Adenocarcinoma (SPLENDID)

ClinicalTrials.gov study NCT07157605. IPD Sharing: UNDECIDED. Countries: 8. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

Risk Factors of Postoperative Complications and Survival Rate in Pancreatic Ductal Adenocarcinoma Patients

ClinicalTrials.gov study NCT06378853. IPD Sharing: NO. Countries: 1. Publications: 0.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov32/100

Volatile Organic Compound Assessment in Pancreatic Ductal Adenocarcinoma

ClinicalTrials.gov study NCT05727020. IPD Sharing: NO. Countries: 1. Publications: 1.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov32/100

Integrative Proteomic Characterization of Pancreatic Ductal Adenocarcinoma

ClinicalTrials.gov study NCT04525209. IPD Sharing: UNDECIDED. Countries: 1. Publications: 2.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

Study Investigating the Association of NP137 With mFOLFIRINOX in Locally Advanced Pancreatic Ductal Adenocarcinoma

ClinicalTrials.gov study NCT05546853. IPD Sharing: NO. Countries: 1. Publications: 0.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov32/100

EUS-RFA for Unresectable Pancreatic Ductal Adenocarcinoma

ClinicalTrials.gov study NCT03772756. IPD Sharing: Not stated. Countries: 1. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

Analysis Of The Anxiety-Depressive Pattern, Quality Of Life And Assessment Of Personality in Patients With Pancreatic Ductal Adenocarcinoma (PACT24)

ClinicalTrials.gov study NCT04396093. IPD Sharing: UNDECIDED. Countries: 1. Publications: 10.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

Combined S-1 With DC+CIK As Maintenance Therapy For Advanced Pancreatic Ductal Adenocarcinoma

ClinicalTrials.gov study NCT05955157. IPD Sharing: NO. Countries: 1. Publications: 16.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov32/100

Diagnostic Value of DWI-MRI for Detection of Peritoneal Metastases in High-risk Pancreatic Ductal Adenocarcinoma.

ClinicalTrials.gov study NCT05340569. IPD Sharing: NO. Countries: 1. Publications: 19.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov32/100

Adjuvant Chemoradiation Following Radical Resection of Pancreatic Ductal Adenocarcinoma, a Prospective Cohort Study

ClinicalTrials.gov study NCT04737551. IPD Sharing: Not stated. Countries: 1. Publications: 5.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

HRS-4642 Combined With Nimotuzumab in the Treatment of Recurrent or Metastatic Pancreatic Ductal Adenocarcinoma

ClinicalTrials.gov study NCT06773130. IPD Sharing: NO. Countries: 1. Publications: 1.

closedIPD-NOFeb 2026View details →

ScienceDex guides

Understand access before you commit

These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.

Compare curated datasets

Allen Brain Atlas

Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.

allen-brain-atlas
neuroscienceopenDocumentation, web resources, and API references are available online.
Last verified 2026-04-30Open record

Annotated Behaviour and Observability Dataset (ABODe)

ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.

abode-home-cage
behavioral-neuroscienceopenThe DataShare record exposes download links for annotations, documentation, license text, and the zipped per-snippet data directory.
Last verified 2026-04-30Open record

DANDI Archive for NWB datasets

DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.

dandi-nwb
electrophysiologyopenPublished Dandiset metadata and archive endpoints are available through the production DANDI API.
Last verified 2026-04-30Open record

International Brain Laboratory public data

The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.

ibl
behavioral-neuroscienceopenPublic sessions can be searched and loaded from the IBL public data server through ONE.
Last verified 2026-04-29Open record

OpenNeuro

OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.

openneuro
neuroscienceopenPublished datasets are available on demand over the internet.
Last verified 2026-04-29Open record